LetterCorrespondence
Infection Risks During Longterm Rituximab Therapy Change Over Time
EMILIO BESADA and JOHANNES C. NOSSENT
The Journal of Rheumatology February 2013, 40 (2) 203; DOI: https://doi.org/10.3899/jrheum.121247
EMILIO BESADA
Professor of Medicine, Rheumatology, Institute for Clinical Medicine, University in Tromsø, Tromsø,
Norway.
MDJOHANNES C. NOSSENT
Professor of Medicine, Rheumatology, Institute for Clinical Medicine, University in Tromsø, Tromsø,
Norway.
MD, PhDREFERENCES
- 1.↵
- Roll P,
- Ostermeier E,
- Haubitz M,
- Lovric S,
- Unger L,
- Holle J,
- et al.
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- Gottenberg JE,
- Ravaud P,
- Bardin T,
- Cacoub P,
- Cantagrel A,
- Combe B,
- et al; and
- Autoimmunity and Rituximab Registry and French Society of Rheumatology
- 7.↵
- 8.↵
- Besada E,
- Koldingsnes W,
- Nossent J
In this issue
The Journal of Rheumatology
Vol. 40, Issue 2
1 Feb 2013
Infection Risks During Longterm Rituximab Therapy Change Over Time
EMILIO BESADA, JOHANNES C. NOSSENT
The Journal of Rheumatology Feb 2013, 40 (2) 203; DOI: 10.3899/jrheum.121247